BIOMARIN PHARMACEUTICAL INC Contracts & Agreements

Waiver Letter, dated as of April 11, 2024, by Elliott Investment Management L.P., Elliott Associates, L.P. and Elliott International, L.P., to the Cooperation Agreement, dated as... (Filed With SEC on April 26, 2024)

Cooperation Agreement, dated as of December 20, 2023, by and among the Company, Elliott Investment Management L.P., Elliott Associates, L.P. and Elliott International, L.P (Filed With SEC on December 20, 2023)

Separation Agreement and General Release by and between BioMarin Pharmaceutical Inc. and Jean-Jacques Bienaim, dated October 30, 2023 (Filed With SEC on November 3, 2023)

Consulting Agreement by and between BioMarin Pharmaceutical Inc. and Jean-Jacques Bienaim, dated October 30, 2023 (Filed With SEC on November 3, 2023)

Employment Agreement by and between BioMarin Pharmaceutical Inc. and Alexander Hardy, dated October 30, 2023 (Filed With SEC on November 3, 2023)

BioMarin Pharmaceutical Inc. 2017 Equity Incentive Plan, as amended on April 3, 2023 (Filed With SEC on August 2, 2023)

Form of Agreement Regarding (Filed With SEC on February 27, 2023)

Form of Agreement Regarding Restricted Stock Units for the BioMarin Pharmaceutical Inc. 2017 Equity Incentive Plan (Filed With SEC on February 27, 2023)

Form of Stock Options Agreement for the BioMarin Pharmaceutical Inc. 2017 Equity Incentive Plan (Filed With SEC on February 27, 2023)

Second Amendment to the Amended and Restated BioMarin Pharmaceutical Inc. Nonqualified Deferred Compensation Plan, as adopted October 4, 2022 (Filed With SEC on October 28, 2022)

BioMarin Pharmaceutical Inc. Summary of Independent Director Compensation (Filed With SEC on October 28, 2022)

Asset Purchase Agreement by and between Eli Lilly and Company, BioMarin Pharmaceutical Inc., and BioMarin International Ltd., dated February 8, 2022. Portions of this exhibit have... (Filed With SEC on April 29, 2022)

Second amendment to the Amended and Restated BioMarin Pharmaceutical Inc. Nonqualified Deferred Compensation Plan, as adopted on October 5, 2021 (Filed With SEC on February 25, 2022)

First Amendment, dated May 28, 2021, to the Credit Agreement by and among BioMarin Pharmaceutical Inc., as the Borrower, Bank of America, N.A., as Administrative Agent, Swing Line... (Filed With SEC on July 30, 2021)

Part-Time Employment Agreement with Robert A. Baffi, Ph.D. effective January 1, 2021 (Filed With SEC on February 26, 2021)

Indenture, dated as of May 14, 2020, by and between BioMarin Pharmaceutical Inc. and U.S. Bank National Association, as Trustee, including the Form of Global Note, representing... (Filed With SEC on May 14, 2020)

Description of Capital Stock (Filed With SEC on February 27, 2020)

BioMarin Pharmaceutical Inc. Summary of Independent Director Compensation (Filed With SEC on October 29, 2019)

First Amendment to the Amended and Restated BioMarin Pharmaceutical Inc. Nonqualified Deferred Compensation Plan, as adopted June 4, 2019 (Filed With SEC on August 2, 2019)

BioMarin Pharmaceutical Inc. Amended and Restated 2006 Employee Stock Purchase Plan, as amended and restated April 12, 2019 (Filed With SEC on August 2, 2019)

BioMarin Pharmaceutical Inc. 2017 Equity Incentive Plan, as adopted April 10, 2017 and amended April 12, 2019 (Filed With SEC on August 2, 2019)

First Amendment to Credit Agreement dated as of March 15, 2018, by and among BioMarin Pharmaceutical Inc., the lenders party thereto, and Bank of America, N.A. as Administrative... (Filed With SEC on April 27, 2018)

Asset Purchase Agreement by and between Novartis Pharma AG, BioMarin Pharmaceutical Inc. and BioMarin Commercial Ltd., dated as of November 21, 2017 (Filed With SEC on February 26, 2018)

BioMarin Pharmaceutical Inc. Summary of Independent Director Compensation (Filed With SEC on October 31, 2017)

BIOMARIN PHARMACEUTICAL INC. (aDelaware corporation) 0.599% Senior Subordinated Convertible Notes due 2024 UNDERWRITING AGREEMENT (Filed With SEC on August 11, 2017)

BIOMARIN PHARMACEUTICAL INC., Issuer AND WILMINGTON TRUST, NATIONAL ASSOCATION, Trustee INDENTURE Dated as of August 11, 2017 Debt Securities TABLE OF CONTENTS (Filed With SEC on August 11, 2017)

FIRST SUPPLEMENTAL INDENTURE DATED AS OF AUGUST 11, 2017 TO INDENTURE DATED AS OF AUGUST 11, 2017 BETWEEN BIOMARINPHARMACEUTICAL INC. AND WILMINGTON TRUST, NATIONAL ASSOCIATION,... (Filed With SEC on August 11, 2017)

Settlement and License Agreement (Filed With SEC on August 2, 2017)

BIOMARIN PHARMACEUTICAL INC. 2017 Equity Incentive Plan (the Plan) STOCK OPTIONS AGREEMENT (Filed With SEC on June 12, 2017)

BIOMARIN PHARMACEUTICAL INC. 2017 Equity Incentive Plan (the Plan) Agreement Regarding Restricted Stock Units (Filed With SEC on June 12, 2017)

BIOMARIN PHARMACEUTICAL INC. 2017 Equity Incentive Plan (the Plan) Agreement Regarding Performance Stock Awards in the Form of Restricted Stock Units (Filed With SEC on June 12, 2017)

FIRST AMENDMENT TO THE AMENDED AND RESTATED Termination and Transition Agreement (Filed With SEC on February 27, 2017)

INDEMNIFICATION AGREEMENT (Filed With SEC on December 19, 2016)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on December 19, 2016)

BIOMARIN PHARMACEUTICAL INC. 2006 Share Incentive Plan (as amended and restated on April 16, 2015) (the Plan) Form of Amendment to Agreement Regarding Restricted Share Units (Filed With SEC on December 9, 2016)

BIOMARIN PHARMACEUTICAL INC. (aDelaware corporation) 7,500,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on August 11, 2016)

AMENDED AND RESTATED TERMINATION AND TRANSITION AGREEMENT by and between BioMarin Pharmaceutical Inc., a Delaware corporation, and Ares Trading S.A. 1 (Filed With SEC on February 29, 2016)

TERMINATION AGREEMENT by and between BioMarin Pharmaceutical Inc., a Delaware corporation, and Ares Trading S.A. 1 (Filed With SEC on February 29, 2016)

TERMINATION AND TRANSITION AGREEMENT by and between BioMarin Pharmaceutical Inc., a Delaware corporation, and Ares Trading S.A. 1 (Filed With SEC on February 29, 2016)

AMENDED AND RESTATED TERMINATION AND TRANSITION AGREEMENT by and between BIOMARIN PHARMACEUTICAL INC., a Delaware corporation, and ARES TRADING S.A. - 1 - (Filed With SEC on January 7, 2016)

TERMINATION AGREEMENT by and between BIOMARIN PHARMACEUTICAL INC., a Delaware corporation, and ARES TRADING S.A. - 1 - (Filed With SEC on January 7, 2016)

TERMINATION AND TRANSITIONAGREEMENT by and between BIOMARIN PHARMACEUTICAL INC., a Delaware corporation, and ARES TRADING S.A. - 1 - (Filed With SEC on January 7, 2016)

Settlement and License Agreement (Filed With SEC on November 2, 2015)

ASSET PURCHASE AGREEMENT BY AND BETWEEN BioMarin Pharmaceutical Inc. AND Medivation, Inc. August 21, 2015 ASSET PURCHASE AGREEMENT (Filed With SEC on October 7, 2015)

BIOMARIN PHARMACEUTICAL INC. 2006 SHARE INCENTIVE PLAN (As amended and restated on April 16, 2015) PLAN DOCUMENT (Filed With SEC on June 15, 2015)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on June 15, 2015)

BIOMARIN PHARMACEUTICAL INC. 2014 Inducement Plan (the Plan) STOCK OPTIONS AGREEMENT (Filed With SEC on March 2, 2015)

BIOMARIN PHARMACEUTICAL INC. 2014 Inducement Plan (the Plan) Agreement Regarding Restricted Share Units (Filed With SEC on March 2, 2015)

BIOMARIN PHARMACEUTICAL INC. (aDelaware corporation) 8,500,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 23, 2015)

FORM OF CONTINGENT VALUE RIGHTSAGREEMENT BETWEEN BIOMARINPHARMACEUTICAL INC., BIOMARIN FALCONS B.V. and AMERICAN STOCKTRANSFER & TRUST COMPANY, LLC, AS RIGHTS AGENT Dated as of... (Filed With SEC on January 16, 2015)

BIOMARIN PHARMACEUTICAL INC. 2014 INDUCEMENT PLAN PLAN DOCUMENT (Filed With SEC on December 23, 2014)

ASSET PURCHASE AGREEMENT BY AND BETWEEN REGENERON IRELAND, BIOMARIN PHARMACEUTICAL INC. AND BIOMARIN GALNS LTD. July 29, 2014 ASSET PURCHASE AGREEMENT (Filed With SEC on October 28, 2014)

BIOMARIN PHARMACEUTICAL INC. Amended and Restated Severance Plan and Summary Plan Description Amended and Restated Effective October 7, 2014 (Filed With SEC on October 14, 2014)

AMENDED AND RESTATED BIOMARIN PHARMACEUTICAL INC. NONQUALIFIED DEFERRED COMPENSATION PLAN AMENDED AND RESTATED BIOMARIN PHARMACEUTICAL INC. NONQUALIFIED DEFERRED COMPENSATION PLAN... (Filed With SEC on October 14, 2014)

BIOMARIN PHARMACEUTICAL INC. AMENDED AND RESTATED 2006 EMPLOYEE STOCK. PURCHASE PLAN BIOMARIN PHARMACEUTICAL INC. AMENDED AND RESTATED 2006 EMPLOYEE STOCK PURCHASE PLAN (as... (Filed With SEC on June 10, 2014)

AMENDED AND RESTATED BIOMARIN PHARMACEUTICAL INC. NONQUALIFIED DEFERRED COMPENSATION PLAN AMENDED AND RESTATED BIOMARIN PHARMACEUTICAL INC. NONQUALIFIED DEFERRED COMPENSATION PLAN... (Filed With SEC on May 2, 2014)

BIOMARIN PHARMACEUTICAL INC. (a Delaware corporation) 1,500,000Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on March 6, 2014)

CONTRACT OF PURCHASE AND SALE AND JOINT ESCROW INSTRUCTIONS BY AND AMONG SRCORPORATE CENTER PHASE ONE, LLC, A DELAWARE LIMITED LIABILITY COMPANY AND SR CORPORATECENTER PHASE TWO,... (Filed With SEC on February 26, 2014)

BioMarin Pharmaceutical Inc. INDENTURE Dated as ofOctober 15, 2013 Wilmington Trust, National Association, a national banking association, as Trustee TABLE OF CONTENTS (Filed With SEC on October 15, 2013)

FIRST SUPPLEMENTAL INDENTURE DATED AS OF OCTOBER 15, 2013 TO INDENTURE DATED AS OF OCTOBER 15, 2013 BETWEEN BIOMARINPHARMACEUTICAL INC. AND WILMINGTON TRUST, NATIONAL ASSOCIATION,... (Filed With SEC on October 15, 2013)

SECOND SUPPLEMENTAL INDENTURE DATED AS OF OCTOBER 15, 2013 TO INDENTURE DATED AS OF OCTOBER 15, 2013 BETWEEN BIOMARINPHARMACEUTICAL INC. AND WILMINGTON TRUST, NATIONAL... (Filed With SEC on October 15, 2013)

BIOMARIN PHARMACEUTICAL INC. (aDelaware corporation) 0.75% Senior Subordinated Convertible Notes due 2018 1.50% Senior Subordinated Convertible Notes due 2020 UNDERWRITING... (Filed With SEC on October 11, 2013)

BIOMARIN PHARMACEUTICAL INC. Amended and Restated Severance Plan and Summary Plan Description Amended and Restated Effective July 29, 2013 (the Effective Date) (Filed With SEC on July 30, 2013)

BIOMARIN PHARMACEUTICAL INC. 2006 Share Incentive Plan (thePlan) Agreement Regarding Restricted Stock Units (Filed With SEC on May 16, 2013)

CONFIDENTIAL TREATMENT REQUESTED Redacted portions are indicatedby [****]. Redacted portions filed separately with Confidential Treatment Application. SECOND AMENDMENT TO STOCK... (Filed With SEC on February 26, 2013)

AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on December 18, 2012)

AMENDMENT NO. 1 TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on December 18, 2012)

AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on December 18, 2012)

AMENDMENT NO. 3 TO EMPLOYMENT AGREEMENT (Filed With SEC on December 18, 2012)

AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT (Filed With SEC on December 18, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on September 5, 2012)

SEVERANCE AGREEMENT AND RELEASE OF ALL CLAIMS (Filed With SEC on September 5, 2012)

CONFIDENTIAL TREATMENT REQUESTED Redacted portions are indicated by[****] Redacted portions filed separately with Confidential Treatment Application. FIRST AMENDMENT TO STOCK... (Filed With SEC on August 2, 2012)

BIOMARIN PHARMACEUTICAL INC. 2006 Share Incentive Plan (as Amended andRestated 2010) STOCK OPTIONS AGREEMENT (Filed With SEC on August 2, 2012)

BIOMARIN PHARMACEUTICAL INC. 2006 Share Incentive Plan (thePlan) Agreement Regarding Restricted Stock Units (Filed With SEC on August 2, 2012)

BIOMARIN PHARMACEUTICAL INC. 2012 Inducement Plan (thePlan) STOCK OPTIONS AGREEMENT (Filed With SEC on August 2, 2012)

BIOMARIN PHARMACEUTICAL INC. 2012 Inducement Plan (thePlan) Agreement Regarding Restricted Stock Units (Filed With SEC on August 2, 2012)

BIOMARIN PHARMACEUTICAL INC. (a Delaware corporation) 6,500,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 1, 2012)

AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT (Filed With SEC on May 24, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on May 9, 2012)

BIOMARIN PHARMACEUTICAL INC. 2012 INDUCEMENT PLAN PLAN DOCUMENT (Filed With SEC on May 9, 2012)

AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on May 9, 2012)

ASSET PURCHASE AGREEMENT (Filed With SEC on February 22, 2012)

LEASE SAN RAFAEL CORPORATE CENTER 770 Lindaro Street San Rafael, California SR CORPORATE CENTER PHASE TWO, LLC, a Delaware limited liability company as Landlord, and BIOMARIN... (Filed With SEC on February 22, 2012)

LEASE SAN RAFAEL CORPORATE CENTER 790 Lindaro Street San Rafael, California SR CORPORATE CENTER PHASE TWO, LLC, a Delaware limited liability company as Landlord, and BIOMARIN... (Filed With SEC on February 22, 2012)

SEVERANCE AGREEMENT AND RELEASE OF ALL CLAIMS (Filed With SEC on February 22, 2012)

CONFIDENTIAL TREATMENT REQUESTED Redacted portions are indicatedby [****]. Redacted portions filed separately with Confidential Treatment Application. ASSET PURCHASE AGREEMENT IN... (Filed With SEC on August 1, 2011)

CONFIDENTIAL TREATMENT REQUESTED Redacted portions are indicated by [****]. Redacted portions filed separately with Confidential Treatment Application. STOCK PURCHASE AGREEMENT by... (Filed With SEC on May 3, 2010)

CONFIDENTIAL TREATMENT REQUESTED Redactedportions are indicated by [****]. Redacted portions filed separately with (Filed With SEC on February 26, 2010)

BIOMARIN PHARMACEUTICAL INC. Severance Plan and Summary Plan Description BIOMARIN PHARMACEUTICAL INC. (Filed With SEC on July 31, 2009)

SEVERANCE AGREEMENT AND RELEASE OF ALL CLAIMS (Filed With SEC on June 3, 2009)

CONSULTING AGREEMENT (Filed With SEC on June 3, 2009)

EMPLOYMENT AGREEMENT (Filed With SEC on March 23, 2009)

BIOMARIN PHARMACEUTICAL INC. a Delaware corporation (Filed With SEC on February 27, 2009)

CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on February 27, 2009)

CONFIDENTIAL TREATMENT REQUESTED Redacted Portions are indicated by [****] (Filed With SEC on February 27, 2009)

AMENDMENT NO. 1 TO DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on February 27, 2009)

AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 27, 2009)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on December 23, 2008)

AMENDED AND RESTATED BIOMARIN PHARMACEUTICAL INC. (Filed With SEC on December 23, 2008)

BIOMARIN PHARMACEUTICAL INC. 2006 SHARE INCENTIVE PLAN (Filed With SEC on December 23, 2008)

CONFIDENTIAL TREATMENT REQUESTED Redacted Portions are indicated by [****] MANUFACTURING, MARKETING AND SALES AGREEMENT (Filed With SEC on February 28, 2008)

CONFIDENTIAL TREATMENT REQUESTED Redacted Portions are indicated by [****] AMENDED AND RESTATED COLLABORATION AGREEMENT (Filed With SEC on February 28, 2008)

CONFIDENTIAL TREATMENT REQUESTED Redacted Portions are indicated by [****] MEMBERS AGREEMENT (Filed With SEC on February 28, 2008)

EMPLOYMENT AGREEMENT (Filed With SEC on August 9, 2007)

EMPLOYMENT AGREEMENT (Filed With SEC on May 3, 2007)

CONFIDENTIAL TREATMENT REQUESTED Redacted portions are indicated by [****] (Filed With SEC on May 3, 2007)

(a Delawarecorporation) 1.875% Senior Subordinated Convertible Notes due 2017 PURCHASE AGREEMENT (Filed With SEC on April 23, 2007)

SECOND SUPPLEMENTAL INDENTURE Dated as of April 23, 2007 (Filed With SEC on April 23, 2007)

BIOMARIN PHARMACEUTICAL INC. 1.875% SENIOR SUBORDINATED CONVERTIBLE NOTES DUE 2017 NO. A1 CUSIP: 09061G AD3 (Filed With SEC on April 23, 2007)

BIOMARIN PHARMACEUTICAL INC. AMENDED AND RESTATED (Filed With SEC on August 3, 2006)

AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT (Filed With SEC on May 12, 2006)

LICENSE AGREEMENT (Filed With SEC on May 4, 2006)

PURCHASE AND SALE AGREEMENT AND JOINT ESCROW INSTRUCTIONS (46 Galli Drive Novato,CA) (Filed With SEC on May 4, 2006)

FIRST AMENDMENT TO PURCHASE AND SALE AGREEMENT AND JOINT ESCROW INSTRUCTIONS (46 Galli Drive Novato, CA) (Filed With SEC on May 4, 2006)

BioMarin Pharmaceutical Inc. INDENTURE Dated as of March 29, 2006 (Filed With SEC on March 29, 2006)

FIRST SUPPLEMENTAL INDENTURE Dated as of March 29, 2006 (Filed With SEC on March 29, 2006)

BioMarin Pharmaceutical Inc. 2.50% Senior Subordinated Convertible Notes due 2013 No. A1 CUSIP: 09061G AC5 (Filed With SEC on March 29, 2006)

BIOMARIN PHARMACEUTICAL INC. (a Delaware corporation) 2.5% Senior Subordinated Convertible Notes due 2013 PURCHASE AGREEMENT (Filed With SEC on March 28, 2006)

BIOMARIN PHARMACEUTICAL INC. (a Delaware corporation) 9,000,000 Shares of Common Stock (Filed With SEC on March 28, 2006)

CONFIDENTIAL TREATMENT REQUESTED Redacted Portions are indicated by [****] (Filed With SEC on March 7, 2006)

FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on December 19, 2005)

AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on December 19, 2005)

BIOMARIN PHARMACEUTICAL INC. NONQUALIFIED DEFERRED COMPENSATION PLAN BIOMARIN PHARMACEUTICAL INC. NONQUALIFIED DEFERRED COMPENSATION PLAN RECITALS (Filed With SEC on December 2, 2005)

SEVERANCE AGREEMENT (Filed With SEC on August 24, 2005)

BIOMARIN PHARMACEUTICAL INC. (Filed With SEC on July 15, 2005)

Redacted portions are indicated by [****]. LICENSE AGREEMENT (Filed With SEC on July 6, 2005)

Redacted portions are indicated by [****]. DEVELOPMENT, LICENSE AND COMMERCIALIZATIONAGREEMENT Dated May 13, 2005 (Filed With SEC on July 6, 2005)

FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on July 5, 2005)

AGREEMENT (Filed With SEC on June 1, 2005)

EMPLOYMENT AGREEMENT (Filed With SEC on May 12, 2005)

CONFIDENTIAL TREATMENT REQUESTED Redacted portions are indicated by [****] LICENSE AND SUPPLY AGREEMENT (Filed With SEC on May 5, 2005)

SETTLEMENT AGREEMENT AND MUTUAL RELEASE (Filed With SEC on March 16, 2005)

AMENDMENT TO SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 16, 2005)

AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on March 16, 2005)

SEVERANCE AGREEMENT AND RELEASE OF ALL CLAIMS (Filed With SEC on March 16, 2005)

RedactedPortions are indicated by [****] License Agreement (Filed With SEC on March 16, 2005)

RedactedPortions are indicated by [****] LICENSE AGREEMENT (Filed With SEC on March 16, 2005)

CONFIDENTIAL TREATMENT REQUESTED Redacted Portions are indicated by [****] (Filed With SEC on March 16, 2005)

SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 16, 2005)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on March 16, 2005)

CONFIDENTIAL TREATMENT REQUESTED Redacted Portions are indicated by [****] CRO SERVICES AGREEMENT (Filed With SEC on March 16, 2005)

SEPARATION AGREEMENT AND RELEASE OF ALL CLAIMS (Filed With SEC on November 9, 2004)

FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on November 9, 2004)

BIOMARIN PHARMACEUTICAL INC. 1997 STOCK PLAN (Filed With SEC on August 9, 2004)

BIOMARIN PHARMACEUTICAL INC. 1998 DIRECTOR OPTION PLAN, AS AMENDED (Filed With SEC on August 9, 2004)

THIRD AMENDMENT TO LEASE (Filed With SEC on August 9, 2004)

BIOMARIN PHARMACEUTICAL INC. LOAN ANDSECURITY AGREEMENT (Filed With SEC on August 9, 2004)

ASSET PURCHASE AGREEMENT among (Filed With SEC on June 2, 2004)

SECURITIES PURCHASE AGREEMENT among MEDICIS PHARMACEUTICAL CORPORATION, (Filed With SEC on June 2, 2004)

LICENSE AGREEMENT (Filed With SEC on June 2, 2004)

Portions of this document have been redacted pursuant to a Request for Confidential Treatment. (Filed With SEC on February 27, 2004)

BIOMARIN PHARMACEUTICAL INC. and WILMINGTON TRUST COMPANY as Trustee (Filed With SEC on August 12, 2003)

BIOMARIN PHARMACEUTICAL INC. (Filed With SEC on August 12, 2003)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 12, 2003)

Amendment No. 2 to BioMarin Pharmaceutical Inc. 1998 Director Option Plan (Filed With SEC on August 12, 2003)

BAYVIEW BUSINESS PARK (Filed With SEC on August 12, 2003)

$125,000,000 Principal Amount BioMarinPharmaceutical Inc. 3.50% Convertible Subordinated Notes due 2008 PURCHASE AGREEMENT (Filed With SEC on August 12, 2003)

Amendment No. 1 to BioMarin Pharmaceutical Inc. 1998 DirectorOption Plan (Filed With SEC on May 15, 2003)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on May 15, 2003)

($0.001 par value) UNDERWRITINGAGREEMENT (Filed With SEC on February 21, 2003)

Category

Industry

Companies

Contracts

BIOMARIN PHARMACEUTICAL INC Contracts & Agreements